You are here

  • Home
  • Archive
  • Volume 79, Issue Suppl 1
  • THU0176 OLOKIZUMAB IMPROVES PATIENT REPORTED OUTCOMES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS INADEQUATELY CONTROLLED BY METHOTREXATE: RESULTS FROM THE DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE III STUDY (CREDO-1)

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Thursday, 04 June 2020
Rheumatoid arthritis - biological DMARDs
THU0176 OLOKIZUMAB IMPROVES PATIENT REPORTED OUTCOMES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS INADEQUATELY CONTROLLED BY METHOTREXATE: RESULTS FROM THE DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE III STUDY (CREDO-1)

 

Online download statistics by month:

Online download statistics by month: June 2020 to March 2024

AbstractFullPdf
Jun 20203302
Jul 20202200
Aug 20202800
Sep 20201200
Oct 20201500
Nov 20201001
Dec 20201200
Jan 20213600
Feb 20211300
Mar 20213101
Apr 2021400
Jun 2021203
Jul 2021001
Sep 2021200
Oct 20211000
Nov 20211101
Dec 20211000
Jan 20221601
Feb 20221100
Mar 2022600
May 20222300
Jun 20221601
Jul 20222200
Aug 20221400
Sep 20224801
Oct 2022900
Nov 20225700
Dec 20221200
Jan 2023800
Feb 20231101
Mar 20232603
Apr 20231300
May 20231501
Jun 20233200
Jul 20231600
Aug 2023801
Sep 20231400
Oct 20231100
Nov 20231500
Dec 20231000
Jan 2024700
Feb 2024200
Mar 2024800
Total681018